Tag: major depressive disorder
-
Rabiya Mateo Opens Up About Depression: A Courageous Battle to Survive
Her Revelation and What It Means Filipino beauty queen and television host Rabiya Mateo recently opened up about a deeply personal struggle that affected her life long before she became a public figure. In a candid message posted on social media, she revealed that she was diagnosed with major depressive disorder and anxious distress in…
-
Rabiya Mateo Opens Up About Depression: A Bold Conversation on Mental Health
Rabiya Mateo, the Filipino beauty queen turned TV host, has publicly shared a candid account of her struggle with depression and anxiety. In a heartfelt post dated January 16, 2025, Mateo revealed that she was diagnosed with major depressive disorder and anxious distress. Her admission marks a significant moment in the ongoing conversation about mental…
-
FDA Clears At-Home Neuromodulation Device Proliv Rx for Major Depressive Disorder
Overview: A New at-Home Option for Major Depressive Disorder The U.S. Food and Drug Administration has cleared Proliv™Rx, an at-home neuromodulation device designed to be used as an adjunctive therapy for adults with major depressive disorder (MDD) who have not achieved satisfactory improvement after at least one prior treatment. This marks a significant step in…
-
Multi-System Biomarkers for Suicide Risk in MDD: Erythroid, Inflammation, and Metabolism
Introduction: The Need for Multi-System Biomarkers in MDD Major Depressive Disorder (MDD) remains a leading cause of disability worldwide, with suicide risk representing a critical and urgent challenge for clinicians. Traditional risk assessment often relies on clinical history and self-reported symptoms, which can miss biologically meaningful signals. Emerging research points to a multi-system model of…
-
Multi-system Biomarkers for Suicide Risk in Major Depressive Disorder: Erythroid, Inflammatory, and Metabolic Integration
Introduction: The Need for Multi-system Biomarkers in MDD Major Depressive Disorder (MDD) remains a leading cause of disability worldwide, with suicide risk representing a critical and urgent concern. Traditional risk assessment relies heavily on clinical history and self-reported symptoms, which can fail to capture dynamic biological processes that contribute to suicidality. Emerging evidence suggests that…
-
Multi-System Biomarkers for Suicide Risk in Major Depressive Disorder
Understanding the Need for Multi-System Biomarkers in MDD Major Depressive Disorder (MDD) remains a leading cause of disability worldwide, with suicide risk presenting one of its most urgent clinical challenges. Traditional risk assessments rely on psychosocial factors and clinical history, but they often fail to capture the biological underpinnings that can signal imminent danger. A…